Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $30.1550 (-2.73%) ($30.1550 - $31.4300) on Mon. May. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 20 | Latest Price | $30.1550(-2.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.6% a day on average for past five trading days. | Weekly Trend | HALO declines -4.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IFRA(42%) IWO(39%) IWM(37%) XBI(36%) IBB(34%) | Factors Impacting HALO price | HALO will decline at least -1.415% in a week (0% probabilities). UUP(-16%) VXX(-15%) TBT(-8%) VIXM(-7%) IGOV(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $20.31(-32.65%) | Resistance Level | $33.52 | 5 Day Moving Average | $31.25(-3.5%) | 10 Day Moving Average | $31.89(-5.44%) | 20 Day Moving Average | $33.52(-10.04%) | To recent high | -40.1% | To recent low | 0% | Market Cap | $4.121b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |